YUHASpace Repository
YUHSpace
BROWSE
4
10
Cited 0 times in 
Cited 0 times in 
Zanidatamab in HER2-Positive Metastatic Biliary Tract Cancer
- Authors
- Pant, Shubham ; Fan, Jia ; Oh, Do-Youn ; Choi, Hye Jin ; Kim, Jin Won ; Chang, Heung-Moon ; Bao, Lequn ; Sun, Hui-Chuan ; Macarulla, Teresa ; Xie, Feng ; Metges, Jean-Phillippe ; Ying, Jie'er ; Bridgewater, John ; Lee, Myung-Ah ; Tejani, Mohamedtaki A. ; Chen, Emerson Y. ; Wasan, Harpreet ; Ducreux, Michel ; Bao, Yuanyuan ; Wu, Xiaotian ; Zhao, Yi ; Garfin, Phillip M. ; Gable, Jonathon ; Harding, James J.
- Citation
- JAMA ONCOLOGY, 2025-11
- Journal Title
- JAMA ONCOLOGY
- ISSN
- 2374-2437
- Issue Date
- 2025-11
- Abstract
- This follow-up analysis of the phase 2 HERIZON-BTC-01 trial evaluates the efficacy, patient-reported outcomes, and safety profile of zanidatamab in patients with ERBB2-amplified biliary tract cancer with an HER2 immunohistochemistry score of 3+ or 2+ after 33 months of follow-up.
- Appears in Collections:
- 1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
- Yonsei Authors
-
Choi, Hye Jin(최혜진)
https://orcid.org/0000-0001-5917-1400
- 사서에게 알리기
-
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
-
- License
DSpace Software Copyright © 2002-2017 Duraspace
Yonsei University Medical Library All right Reserves. / TEL:02-2228-2915 /
YUHSpace는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.